IVF Experts call for early implementation of Assisted Reproductive Technology Laws

New Delhi:  Given mindless utilisation of infertility treatments and discard of age factors, fertility experts strongly recommend urgent revisit on Assisted Reproductive Technology (ART) Bill 2017 by the government to properly regulate and monitor it in the country.

Recently a 74-years old woman delivered twins and that alerted the fertility fraternity. As per the Bill —the reproductive technology services shall not be available to a woman below the age of 18 years and above the age of 45 years.

Talking to Medicare News, Dr Archana Dhawan Bajaj, Gynaecologist, Obstetrician and IVF Expert, Nurture IVF Centre says, ‘The government needs urgently to revisit the Bill. Due to a lack of strict regulation through ART laws, we are witnessing a surge in unethical practices and rampant commercialisation of IVF. As an IVF expert, I also strongly recommend that the ART should not be made available to women below the age of 18 and above the age of 45,”

It is a proven fact that women are most fertile between the ages of 15 and 30.

Being most ethical of IVF centres and most vocal about need to regulate the assisted birthing technology, Dr Archana further said, ‘IVF at advanced ages come with risks of pregnancy loss, fetal anomalies, stillbirth, and obstetric complications. It is also associated with medical comorbidities in mother due to increasing maternal age like hypertension, diabetes and heart problem. It poses risks to both mother and child.’

The Indian Fertility Society (IFS) has also condemned the mindless misutilization of IVF technologies.

Appealing all its members and health professionals to abstain from such unethical malpractice which may risk the lives of the patients, offsprings and future generation, Dr. Pankaj Talwar, Secretary General IFS, said, ‘We, as reproductive health professionals, have a great responsibility towards society and couples. The ART should not be made available to women below the age of 18 and above the age of 45.’

In India, currently, there is no prohibition on the ART above 45 years of age or below 18 years.

Dr. Anoop Gupta from Delhi IVF Fertility Research Centre said, ‘The Assisted Reproductive Technology (ART) has come as a boon for infertility treatment. However, this needs to utilise ethically and we need to keep both the health and social aspects of the patient in mind. I strongly recommend that the ART should be available to a woman above the age of eighteen years and below the age of forty-five years.’

The Indian Council of Medical Research (ICMR) has been making efforts to put in place regulations and had drafted the ART Bill. Fertility experts expect that now ICMR would take urgent action to once again re-introduce the Bill in Parliament.

Related Posts

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

Yashoda Medicity lifts Benchmark in Critical Care to New High

With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses